NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-11-04 23:16இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Galaxy Surfactants Q2 PAT Jumps 80.1% YoY to ₹119.8 Cr; EBITDA Rises 68.4%
Galaxy Surfactants reported robust Q2 FY27 consolidated financial results, with revenue growing 36.4% YoY to ₹1,816.8 crore. EBITDA jumped 68.4% YoY to ₹195.9 crore as operating margins expanded by 210 bps to 10.8%, driven by a 56% surge in EBITDA/MT to ₹26,920/MT. Profit after tax surged 80.1% YoY to ₹119.8 crore. For H1 FY27, PAT reached ₹285.7 crore (up 95.7% YoY), surpassing the entire PAT of FY26 (₹267.4 crore).
உச்சம் நம்பிக்கை
என்ன மாறியதுGalaxy Surfactants posted strong Q2 FY27 earnings momentum, expanding operating margins significantly due to product mix enrichment and volume growth in India and AMET.
ஏன் இது முக்கியம்H1 FY27 net profit has already exceeded FY26 full-year profit, indicating a strong cyclical and mix-driven recovery in operating efficiency and profitability.
Q2 FY27 Revenue: ₹1,816.8 கோடிQ2 FY27 EBITDA: ₹195.9 கோடிQ2 FY27 PAT: ₹119.8 கோடிEBITDA/MT: ₹26,920/MTH1 FY27 PAT vs FY26 Full Year PAT: 106.8%
📅 குறுகிய காலம்Earnings beat will likely drive positive sentiment in the near term given the sharp margin expansion and strong volume traction in domestic and AMET markets.
📈 நீண்ட காலம்Consistent volume growth in Specialty Care and premium HPC segments supports structural expansion in per-tonne margins and ROCE over the medium to long term.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical unrest in West Asia impacting Egypt subsidiary, feedstock availability, and freight rates
High-single-digit volume decline in Rest of World (ROW) markets due to elevated shipping costs and logistics bottlenecks
👀 கவனிக்க வேண்டியவை
Track the sustainability of EBITDA/MT above ₹26,000/MT, along with monitoring freight cost and logistics trends affecting the Rest of the World (ROW) export volumes.
Q2 FY27 Revenue at ₹1,810.41 Cr, Up 36.5% YoY; Declares ₹18/Share Interim Dividend
Galaxy Surfactants approved its Q2 FY27 results, reporting consolidated revenue from operations of ₹1,810.41 crore, reflecting a 36.5% YoY growth over ₹1,326.17 crore in Q2 FY26. The Board declared an interim dividend of ₹18 per equity share (face value ₹10) with a record date of November 11, 2026. Additionally, the company approved the re-appointment of Managing Director Mr. K. Natarajan from February 2027 to March 2029, appointed Ms. Roopali Vikram Kamate as Company Secretary effective December 5, 2026, and approved S R B C & CO LLP as statutory auditors for a 5-year term.
உச்சம் நம்பிக்கை
என்ன மாறியதுGalaxy Surfactants announced its Q2 FY27 financial results showing strong top-line recovery, declared an ₹18/share interim dividend, and confirmed leadership continuity and statutory auditor rotation.
ஏன் இது முக்கியம்Top-line growth of 36.5% YoY indicates robust demand across home and personal care (HPC) surfactant markets, while the steady dividend distribution demonstrates ongoing cash-flow generation.
Q2 FY27 Revenue from Operations: ₹1,810.41 கோடிQ2 FY26 Revenue from Operations: ₹1,326.17 கோடிH1 FY27 Revenue from Operations: ₹3,592.31 கோடிInterim Dividend per share: ₹18Dividend Record Date: நவம்பர் 11, 2026
📅 குறுகிய காலம்Ex-dividend adjustment on November 11, 2026, and positive sentiment driven by significant YoY revenue acceleration.
📈 நீண்ட காலம்Leadership continuity under Mr. K. Natarajan supports the long-term expansion into higher-margin specialty care products and growth in Rest of World (ROW) markets.
⚠ அபாய எச்சரிக்கைகள்
Volatility in oleochemical/petrochemical raw material prices
Geopolitical instability affecting Middle East and North Africa operations
👀 கவனிக்க வேண்டியவை
Track operating margins and EBITDA per tonne trends in the full Q2 investor presentation to see if strong top-line growth is translating to sustained profitability amidst raw material price changes.
Galaxy Surfactants Signs Partnership Growth Charter with Unilever Extending 45-Year Tie-Up
Galaxy Surfactants Ltd. has signed a Partnership Growth Charter with global FMCG major Unilever, marking a new phase in their 45-year relationship. The charter serves as a strategic framework to accelerate new chemistries, next-generation surfactant technologies, and bio-based, lower-carbon alternatives. While the filing does not disclose specific contract values or volume commitments, Unilever represents a core customer in the home and personal care segment. Against Galaxy's TTM revenue of ₹5,752 Cr, this agreement reinforces long-term customer stickiness and collaborative R&D pipeline visibility.
உச்சம் நம்பிக்கை
என்ன மாறியதுFormalized an innovation and supply resilience growth charter with Unilever to co-develop sustainable and next-gen surfactant chemistries.
ஏன் இது முக்கியம்Deepens engagement with one of Galaxy's key global FMCG clients and positions the company as a preferred supplier for sustainable, low-carbon surfactant technologies.
📅 குறுகிய காலம்Positive sentiment indicator demonstrating strong multi-decade client retention, though no immediate impact on quarterly revenue run-rates is quantified.
📈 நீண்ட காலம்Enhances long-term competitive moat in specialty green surfactants, ensuring sustained volume allocation and joint technology leadership as FMCG brands transition to bio-based inputs.
⚠ அபாய எச்சரிக்கைகள்
No specific financial or volume commitments disclosed
Client concentration exposure to major global FMCG players
👀 கவனிக்க வேண்டியவை
Track upcoming quarterly management commentaries for any guidance on capital expenditure or revenue share from new bio-based chemistries co-developed under this framework.
₹252.5 Cr Record EBITDA: Galaxy Surfactants Q1 FY27 PAT Jumps 108.7% YoY
Galaxy Surfactants reported its highest-ever quarterly EBITDA of ₹252.5 Cr for Q1 FY27, an 86.9% YoY increase. Revenue grew 38.5% YoY to ₹1,785.2 Cr, driven by a return to double-digit volume growth in India and sustained momentum in Specialty Care. Profitability metrics improved sharply, with EBITDA per Metric Tonne (MT) rising to ₹35,458 from ₹20,009 in the previous year. Despite geopolitical headwinds in the AMET region causing a low-single-digit volume decline, the company saw a strong sequential recovery in that market.
உச்சம் நம்பிக்கை
என்ன மாறியதுGalaxy Surfactants achieved record-high profitability and significant margin expansion (14.1% vs 9.0% TTM) following a period of margin pressure in FY26.
ஏன் இது முக்கியம்The results demonstrate strong pricing power and the successful execution of a high-margin Specialty Care strategy, which has significantly boosted the bottom line despite global supply chain disruptions.
Q1 FY27 Revenue: ₹1,785.2 கோடிQ1 FY27 EBITDA: ₹252.5 கோடிEBITDA லாப வரம்பு: 14.1%EBITDA per MT: ₹35,458Revenue vs TTM Revenue: 34.01%PAT vs TTM PAT: 62.13%
📅 குறுகிய காலம்The stock is likely to react positively to the record-breaking EBITDA and sharp margin improvement which significantly exceeded recent quarterly averages.
📈 நீண்ட காலம்The structural shift toward Specialty Care and recovery in Tier-1 customer demand suggests a higher sustainable earnings base for the company over the coming years.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical instability in the AMET region impacting the Egypt subsidiary
Feedstock price fluctuations
Global supply chain and freight cost volatility
👀 கவனிக்க வேண்டியவை
Watch for the sustainability of the elevated EBITDA/MT levels and the volume recovery trajectory in the AMET (Egypt/West Asia) region amidst ongoing geopolitical tensions.
109% PAT Growth in Q1 FY27: Galaxy Surfactants Reports Strong Margin Recovery
Galaxy Surfactants reported a robust Q1 FY27 with consolidated revenue growing 39.4% YoY to ₹1,781.9 Cr. Net profit surged 108.7% YoY to ₹165.9 Cr, driven by a significant expansion in EBITDA margins to 14.1% from 10.5% in the previous year. Volume growth was led by the India market (double-digit), while the AMET region saw a slight decline due to geopolitical issues. EBITDA per tonne reached a high of ₹35,458, reflecting better product mix and pricing discipline despite volatile raw material costs.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company transitioned from a period of margin pressure to a high-margin environment in Q1 FY27, with EBITDA growing 87% YoY.
ஏன் இது முக்கியம்The results demonstrate the company's ability to pass on raw material costs and benefit from a favorable product mix in Specialty Care, which is critical for long-term profitability.
Q1 FY27 Revenue: ₹1,781.9 கோடிQ1 FY27 PAT: ₹165.9 கோடிEBITDA லாப வரம்பு: 14.1%EBITDA per MT: ₹35,458Revenue vs TTM Revenue: ~34%
📅 குறுகிய காலம்Positive sentiment is expected in the coming weeks due to the sharp recovery in margins and PAT exceeding recent quarterly averages.
📈 நீண்ட காலம்Structural focus on Specialty Care and the recovery in India volumes are positive indicators for long-term growth, though geopolitical risks in Egypt remain a factor.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical disruptions in AMET region impacting Egypt subsidiary
Volatility in Fatty Alcohol prices
Rising crude-linked feedstock costs
👀 கவனிக்க வேண்டியவை
Investors should monitor the sustainability of the high EBITDA/MT and the recovery in the AMET region (Egypt/West Asia) which is currently impacted by geopolitical disruptions.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Galaxy Surfactants Q4 FY26: India Volumes Up 8%, EBITDA at INR 122 Cr Amid Global Headwinds
Galaxy Surfactants reported a mixed Q4 FY26, with India showing resilience through 8% volume growth, while the AMET region faced a 15% decline due to geopolitical disruptions and logistics issues. EBITDA for the quarter stood at INR 122 crores, down from INR 135 crores YoY, with EBITDA per MT contracting to INR 20,114. Despite rising feedstock prices and supply chain challenges in Egypt, the company achieved a 27% annual growth in Specialty volumes. Management remains optimistic about sequential improvement, supported by a recovery in the US market following tariff reversals.
முக்கிய அம்சங்கள்
India volume growth of 8% YoY, driven by a 27% surge in Specialty volumes and steady D2C demand.AMET region volumes declined 15% YoY due to Red Sea disruptions and raw material availability constraints.Q4 EBITDA per metric ton decreased to INR 20,114 from INR 21,715 in the previous year.US specialty pipeline reinitiated post-tariff reversals, leading to sequential volume improvement in the Americas.Launched 'Galsoft Lumithic', a next-generation mild surfactant, targeting the high-growth baby and sensitive care segments.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to manage the lag in passing through rising raw material costs and the stabilization of logistics in the AMET region. The strong traction in high-margin Specialty products in India and the US provides a positive long-term outlook despite near-term margin pressure.
Galaxy Surfactants Q4 FY26: PAT Drops 17.7% to ₹62.4 Cr Despite 14% Revenue Growth
Galaxy Surfactants reported a 14.1% YoY increase in Q4 revenue to ₹1,315 crore, but profitability was significantly impacted by geopolitical tensions in West Asia and supply chain disruptions. PAT for the quarter declined by 17.7% YoY to ₹62.4 crore, with EBITDA margins contracting to 9.3% from 11.7% in the previous year. While the India market showed resilience with high single-digit volume growth, international markets like AMET and ROW faced volume declines due to logistics constraints. The company's specialty care segment remained a bright spot, growing by high single-digits despite the overall flat volume performance.
முக்கிய அம்சங்கள்
Q4 Revenue grew 14.1% YoY to ₹1,315 crore, while FY26 revenue rose 24% to ₹5,270.4 crore.Q4 PAT declined 17.7% YoY to ₹62.4 crore; FY26 PAT fell 12.3% to ₹267.4 crore.EBITDA per MT for Q4 decreased to ₹20,113 from ₹21,715 in the corresponding period last year.India volumes grew by high single-digits, but AMET region witnessed a mid-teens YoY decline in Q4.Specialty Care products saw high single-digit growth in Q4, whereas Performance Surfactants declined by high single-digits.
👀 கவனிக்க வேண்டியவை
Investors should monitor the recovery in the AMET region and the stabilization of logistics costs, as geopolitical risks continue to pressure margins. The resilience in the Indian market and growth in specialty products are positive, but the overall bottom-line decline warrants a cautious approach.
Galaxy Surfactants FY26 Revenue Up 19.6% to ₹3,589 Cr; Recommends ₹22 Final Dividend
Galaxy Surfactants reported a robust 19.6% year-on-year growth in standalone revenue, reaching ₹3,589.07 crore for the full year ended March 31, 2026. The company's Q4FY26 revenue also saw a healthy increase to ₹928.34 crore from ₹814.25 crore in the previous year's quarter. A final dividend of ₹22 per share has been recommended, signaling management's confidence in cash flows. The audit report was clean with an unmodified opinion, ensuring financial transparency.
முக்கிய அம்சங்கள்
Annual standalone revenue from operations rose to ₹3,589.07 crore in FY26 from ₹3,001.27 crore in FY25.Board recommended a final dividend of ₹22 per equity share of face value ₹10.Q4FY26 revenue stood at ₹928.34 crore, representing a 14% increase over Q4FY25.Total annual income reached ₹3,618.70 crore compared to ₹3,027.72 crore in the previous fiscal.Cost of materials consumed for the full year stood at ₹2,802.19 crore versus ₹2,188.85 crore in FY25.
👀 கவனிக்க வேண்டியவை
The strong top-line growth and healthy dividend payout make this a positive update for shareholders. Investors should monitor the impact of rising raw material costs on operating margins in the upcoming earnings call.
Galaxy Surfactants Q3 EBITDA Rises 13% to INR 124 Cr; US Tariffs Slashed to 18%
Galaxy Surfactants reported a 13% YoY increase in Q3 FY26 EBITDA to INR 124 crores, with EBITDA per metric ton improving to INR 20,156. While consolidated volumes remained stable, the Specialty segment showed resilience with high single-digit growth, offsetting a decline in Performance Surfactants. A major structural positive is the reduction of U.S. reciprocal tariffs on Indian exports from 50% to 18%, which is expected to boost North American volumes. Management expects a recovery in the AMET region and India performance volumes starting Q4 FY26.
முக்கிய அம்சங்கள்
Q3 FY26 EBITDA increased 13% YoY to INR 124 crores with EBITDA per MT rising to INR 20,156.Reciprocal tariffs on Indian exports to the U.S. reduced from 50% to 18%, aiding specialty segment competitiveness.India specialty business volume grew by over 35% YoY, despite overall domestic volume growth of mid-single digits.Recognized a one-time exceptional charge of INR 11.9 crores related to the new labor code provisions.Launched 5 new second-generation Sun Care products (GalSORB range) for commercialization in Q4 FY26.
👀 கவனிக்க வேண்டியவை
Investors should focus on the margin expansion potential from the reduced U.S. tariffs and the ramp-up of new specialty products. The stock remains a recovery play as AMET volumes stabilize and high-margin specialty mix increases.
Galaxy Surfactants Q3 Results: Revenue Up 27.6% to ₹1,334 Cr, PAT Declines 8.8% to ₹59 Cr
Galaxy Surfactants reported a strong 27.6% YoY revenue growth in Q3FY26, reaching ₹1,334.3 crore, primarily driven by a robust performance in the Specialty Care segment. However, PAT declined by 8.8% YoY to ₹59 crore, impacted by a ₹11.9 crore statutory charge related to new labor codes and margin compression. While India and ROW regions showed resilience with mid-single-digit volume growth, the AMET region faced a significant high double-digit volume decline due to competitive intensity. The company's EBITDA/MT improved to ₹20,156, reflecting a better product mix despite flat overall volumes.
முக்கிய அம்சங்கள்
Revenue grew 27.6% YoY to ₹1,334.3 crore, while EBITDA rose 13.3% to ₹124.2 crore.PAT decreased by 8.8% YoY to ₹59.0 crore, affected by a ₹11.9 crore exceptional item for labor codes.Specialty Care segment in India delivered a robust 35% YoY volume growth, offsetting softness in performance surfactants.AMET region volumes saw a high double-digit decline due to heightened competition, while ROW grew in mid-single digits.EBITDA per Metric Ton (MT) improved to ₹20,156, supported by a favorable product mix and cost management.
👀 கவனிக்க வேண்டியவை
Investors should monitor the recovery in the AMET region and the impact of US tariff revisions on specialty exports. While the specialty segment shows strong momentum, the decline in bottom-line profitability and flat overall volumes warrant a cautious outlook until margins stabilize.
Galaxy Surfactants Q3FY26: EBITDA Up 13% YoY to ₹124 Cr; Specialty Care Volumes Grow 35% in India
Galaxy Surfactants reported a 27.6% YoY increase in revenue to ₹1,334.3 crore for Q3FY26, despite consolidated volumes remaining flat. EBITDA grew 13.3% YoY to ₹124.2 crore, with EBITDA per MT improving to ₹20,156 due to a favorable product mix and disciplined cost management. PAT declined by 8.8% YoY to ₹59 crore, primarily impacted by a one-time exceptional charge of ₹11.9 crore related to new labor codes. While the AMET region faced a high-teen volume decline due to competition, the Indian specialty segment showed robust 35% growth.
முக்கிய அம்சங்கள்
Revenue increased 27.6% YoY to ₹1,334.3 crore, while EBITDA rose 13.3% to ₹124.2 crore.EBITDA per MT improved to ₹20,156 from ₹17,527 in Q3FY25, reflecting better margin realization.Specialty Care segment in India delivered 35% YoY volume growth, cushioning softness in Tier-1 accounts.AMET region volumes declined in the high teens YoY due to intensified local competition.PAT of ₹59 crore was impacted by a ₹11.9 crore exceptional item for statutory impact of new labor codes.
👀 கவனிக்க வேண்டியவை
Investors should monitor the recovery in the AMET region and the impact of US tariff revisions on exports. The continued shift towards high-margin specialty products and improved EBITDA/MT are positive indicators for long-term margin sustainability.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
